Login / Signup

Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients.

Pierre HoussetSabah KubabAgathe PardonNathalie VittozDogan-Firat BozmanLatifa HanafiValérie CaudwellAnne-Laure Faucon
Published in: Journal of nephrology (2022)
Keyphrases
  • end stage renal disease
  • peritoneal dialysis
  • chronic kidney disease
  • immune response
  • newly diagnosed